Gateway Investment Advisers’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.7M Buy
8,920
+2,066
+30% +$1.16M 0.05% 178
2026
Q1
$3.85M Sell
6,854
-5,441
-44% -$3.49M 0.04% 188
2025
Q4
$8.32M Buy
12,295
+1,851
+18% +$1.26M 0.08% 150
2025
Q3
$6.67M Sell
10,444
-2,595
-20% -$1.58M 0.06% 167
2025
Q2
$6.99M Sell
13,039
-257
-2% -$123K 0.08% 157
2025
Q1
$5.58M Buy
13,296
+947
+8% +$411K 0.06% 186
2024
Q4
$5.11M Buy
12,349
+1,274
+12% +$559K 0.06% 188
2024
Q3
$5.6M Buy
11,075
+134
+1% +$65.1K 0.06% 191
2024
Q2
$5.33M Buy
10,941
+288
+3% +$145K 0.06% 189
2024
Q1
$5.75M Sell
10,653
-955
-8% -$522K 0.07% 197
2023
Q4
$6.44M Buy
11,608
+1,571
+16% +$738K 0.08% 187
2023
Q3
$4.39M Sell
10,037
-58
-0.6% -$28.9K 0.06% 216
2023
Q2
$5.07M Buy
10,095
+3
+0% +$1.44K 0.06% 207
2023
Q1
$5.05M Buy
10,092
+563
+6% +$269K 0.06% 212
2022
Q4
$3.89M Buy
9,529
+19
+0.2% +$7.38K 0.05% 242
2022
Q3
$3.1M Sell
9,510
-32
-0.3% -$11.8K 0.04% 266
2022
Q2
$3.35M Buy
9,542
+252
+3% +$103K 0.04% 270
2022
Q1
$5.08M Sell
9,290
-5
-0.1% -$2.63K 0.05% 235
2021
Q4
$6.12M Sell
9,295
-60
-0.6% -$37.7K 0.06% 216
2021
Q3
$5.82M Buy
9,355
+37
+0.4% +$24.9K 0.06% 217
2021
Q2
$5.88M Sell
9,318
-89
-0.9% -$49.1K 0.06% 225
2021
Q1
$4.6M Sell
9,407
-262
-3% -$131K 0.05% 249
2020
Q4
$4.83M Sell
9,669
-3,052
-24% -$1.37M 0.05% 246
2020
Q3
$5M Sell
12,721
-1,521
-11% -$562K 0.06% 221
2020
Q2
$4.7M Sell
14,242
-170
-1% -$49.2K 0.06% 236
2020
Q1
$3.49M Buy
14,412
+12,611
+700% +$3.29M 0.04% 252
2019
Q4
$470K Sell
1,801
-163
-8% -$43K ﹤0.01% 447
2019
Q3
$534K Sell
1,964
-2,498
-56% -$695K 0.01% 454
2019
Q2
$1.23M Sell
4,462
-100
-2% -$24.6K 0.01% 423
2019
Q1
$1.02M Sell
4,562
-184
-4% -$38K 0.01% 453
2018
Q4
$883K Sell
4,746
-215
-4% -$44.1K 0.01% 474
2018
Q3
$1.24M Sell
4,961
-185
-4% -$44.9K 0.01% 431
2018
Q2
$1.12M Sell
5,146
-330
-6% -$68K 0.01% 444
2018
Q1
$1.05M Sell
5,476
-1,580
-22% -$292K 0.01% 473
2017
Q4
$1.1M Sell
7,056
-799
-10% -$126K 0.01% 481
2017
Q3
$1.22M Sell
7,855
-121
-2% -$19.1K 0.01% 470
2017
Q2
$1.29M Buy
7,976
+601
+8% +$97.6K 0.01% 443
2017
Q1
$1.14M Buy
7,375
+5,328
+260% +$734K 0.01% 447
2016
Q4
$240K Hold
2,047
﹤0.01% 637
2016
Q3
$231K Buy
+2,047
New +$216K ﹤0.01% 634

Other funds holding IDXX

Gateway Investment Advisers's IDXX Position: Q2 2026 in Review

Gateway Investment Advisers increased its Idexx Laboratories (IDXX) stake by 30% in Q2 2026, buying an estimated $1.16M and bringing the position to 8,920 shares worth $4.7M. The position accounts for 0.05% of the portfolio, ranked #178.

Gateway Investment Advisers first reported a position in IDXX in Q3 2016 and has held it in 40 quarters since. The position peaked at $8.32M in Q4 2025. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Gateway Investment Advisers held 8,920 shares of Idexx Laboratories worth $4.7M as of Q2 2026.
  • Gateway Investment Advisers bought 2,066 Idexx Laboratories shares in Q2 2026, an estimated $1.16M.
  • Idexx Laboratories made up 0.05% of Gateway Investment Advisers's portfolio in Q2 2026, its #178 holding.
  • Gateway Investment Advisers first reported a position in Idexx Laboratories in Q3 2016 and has held it in 40 quarters since.
  • Gateway Investment Advisers's Idexx Laboratories position peaked at $8.32M in Q4 2025.
  • 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.